RHYTHM Engineered Heart Tissue (EHT) Devices based on Ion Conductive Guanosine-Quadruplex (GQ) Hydrogels: A Route to Advance In Vitro 3D Cardiac Tissue Models
- Coordinator
- Universiteit Twente, Netherlands
- Runs
- 1 September 2023 to 31 August 2025
- Status
- Running
- EU funding
- €188k
- Total cost
- —
- Partners
- 2 organisations in 2 countries
- Type
- Marie Skłodowska-Curie Action
- Grant agreement
- 101067198
What the project is doing
In the project's own words, from its summary on CORDIS.
In this project, a micro-engineered heart tissue (EHT) device that will advance the physiological relevance of current in vitro 3D cardiac tissue models will be developed. In moving towards this goal, this project will synthesize conductive guanosine-quadruplex (GQ) hydrogels and implement them as cell scaffolds in EHT devices. Key aspects of biomaterials design are the unique conductive and hierarchical 3D fibrous network and the good biocompatibility of GQ hydrogels, which will support cardiac cell culture.
Upon integration in the EHT platform, the mentioned properties of GQ hydrogels will enable electrical stimulation of embedded cardiac cells under mild pacing voltages, thereby promoting the formation of morphologically and functionally mature cardiac tissue. GQ hydrogels will demonstrate high flexibility and potentially broad utility as a biocompatible and conductive biomaterial for in vitro cell experimentation. The outcomes of this project will expand the horizon of pre-clinical 3D cardiac tissue models, paving the way for future approaches to drug testing and personalized cardiovascular medicine.
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Universiteit Twente | Enschede | Netherlands | Coordinator |
| Universitat Bayreuth | Bayreuth | Germany | Associatedpartner |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI